Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Kiyoi

Showing results (131-140 of 270) with videos related to

Pageof 27
Sort By:
Cancer Immunology Research|April 15, 2018
Introduction of Genetically Modified CD3ζ Improves Proliferation and Persistence of Antigen-Specific CTLsKotaro Miyao, Seitaro Terakura, Shingo Okuno, et al.
Nature Communications|April 7, 2026
Ponatinib inhibits LCK and PI3K signaling and promotes CD8<sup>+</sup> T stem cell memory cell developmentYuki Okuhiro, Sachiko Ito, Keisuke Watanabe, et al.
International Journal of Hematology|June 20, 2020
Real-world management of infection during chemotherapy for acute leukemia in Japan: from the results of a nationwide questionnaire-based survey by the Japan Adult Leukemia Study GroupShun-Ichi Kimura, Hiroyuki Fujita, Hiroshi Handa, et al.
Journal of Thrombosis and Haemostasis : JTH|May 1, 2022
VWF-Gly2752Ser, a novel non-cysteine substitution variant in the CK domain, exhibits severe secretory impairment by hampering C-terminal dimer formationShuichi Okamoto, Shogo Tamura, Naomi Sanda, et al.
International Journal of Hematology|October 31, 2008
Mutational analysis of SOS1 gene in acute myeloid leukemiaRyohei Tanizaki, Akira Katsumi, Hitoshi Kiyoi, et al.
Nagoya Journal of Medical Science|March 6, 2015
Rhof promotes murine marginal zone B cell developmentMayuko Kishimoto, Takenori Matsuda, Shougo Yanase, et al.
Oncotarget|January 6, 2017
Emetine elicits apoptosis of intractable B-cell lymphoma cells with MYC rearrangement through inhibition of glycolytic metabolismTomohiro Aoki, Kazuyuki Shimada, Akihiko Sakamoto, et al.
International Journal of Hematology|June 17, 2008
Clinical significance of minimal residual disease in patients with t(8;21) acute myeloid leukemia in JapanHiroto Narimatsu, Masaki Iino, Takuji Ichihashi, et al.
Nature Communications|December 10, 2024
Cullin-5 deficiency promotes chimeric antigen receptor T cell effector functions potentially via the modulation of JAK/STAT signaling pathwayYoshitaka Adachi, Seitaro Terakura, Masahide Osaki, et al.
International Journal of Hematology|August 18, 2005
BMI-1 is highly expressed in M0-subtype acute myeloid leukemiaMasashi Sawa, Kazuhito Yamamoto, Toshiya Yokozawa, et al.
Pageof 27

Showing results (131-140 of 270) with videos related to

Sort By:
Pageof 27
Cancer Immunology Research|April 15, 2018
Introduction of Genetically Modified CD3ζ Improves Proliferation and Persistence of Antigen-Specific CTLsKotaro Miyao, Seitaro Terakura, Shingo Okuno, et al.
Nature Communications|April 7, 2026
Ponatinib inhibits LCK and PI3K signaling and promotes CD8<sup>+</sup> T stem cell memory cell developmentYuki Okuhiro, Sachiko Ito, Keisuke Watanabe, et al.
International Journal of Hematology|June 20, 2020
Real-world management of infection during chemotherapy for acute leukemia in Japan: from the results of a nationwide questionnaire-based survey by the Japan Adult Leukemia Study GroupShun-Ichi Kimura, Hiroyuki Fujita, Hiroshi Handa, et al.
Journal of Thrombosis and Haemostasis : JTH|May 1, 2022
VWF-Gly2752Ser, a novel non-cysteine substitution variant in the CK domain, exhibits severe secretory impairment by hampering C-terminal dimer formationShuichi Okamoto, Shogo Tamura, Naomi Sanda, et al.
International Journal of Hematology|October 31, 2008
Mutational analysis of SOS1 gene in acute myeloid leukemiaRyohei Tanizaki, Akira Katsumi, Hitoshi Kiyoi, et al.
Nagoya Journal of Medical Science|March 6, 2015
Rhof promotes murine marginal zone B cell developmentMayuko Kishimoto, Takenori Matsuda, Shougo Yanase, et al.
Oncotarget|January 6, 2017
Emetine elicits apoptosis of intractable B-cell lymphoma cells with MYC rearrangement through inhibition of glycolytic metabolismTomohiro Aoki, Kazuyuki Shimada, Akihiko Sakamoto, et al.
International Journal of Hematology|June 17, 2008
Clinical significance of minimal residual disease in patients with t(8;21) acute myeloid leukemia in JapanHiroto Narimatsu, Masaki Iino, Takuji Ichihashi, et al.
Nature Communications|December 10, 2024
Cullin-5 deficiency promotes chimeric antigen receptor T cell effector functions potentially via the modulation of JAK/STAT signaling pathwayYoshitaka Adachi, Seitaro Terakura, Masahide Osaki, et al.
International Journal of Hematology|August 18, 2005
BMI-1 is highly expressed in M0-subtype acute myeloid leukemiaMasashi Sawa, Kazuhito Yamamoto, Toshiya Yokozawa, et al.
Pageof 27